Skip to main content
Loading ResearchHub…
References for Cost-effectiveness of etranacogene dezaparvovec compared to eftrenonacog alfa for the treatment of adult patients with severe and moderately severe haemophilia B in Sweden | ResearchHub - ResearchHub